GlassScriptPhysician profile
Roxana Martinez
NPI 1962030619
$5,880.34
in general payments reported to CMS, 2019-2025
5 companies · $5,880 in 2025
The $5,880 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $5,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,750 · Food and Beverage: $1,420 · Travel and Lodging: $644 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,750.00 |
| Food and Beverage | $1,419.62 |
| Travel and Lodging | $643.50 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,750.00 | 2025 | |
| Stryker Corporation | $1,083.54 | 2025 | Mako, Accolade, Insignia |
| Zimmer Biomet Holdings, INC. | $726.52 | 2025 | Oxford, Persona, Oxford Partial Knee |
| Medical Device Business Services, INC. | $234.28 | 2025 | Velys |
| Bone Support INC. | $86.00 | 2025 | Cerament G, Ceramentbone Void Filler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxana Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.